Pre-market responding positively to Kazia's new medication Lycanthropex, the innovative glandular treatment for werewolfism that far surpasses in efficacy GlaxoSmithKline's Wolfsbanesol. As they say on Stock Twits, "This will EASILY close above $50 by Friday!"
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-1277
-
- There are more pages in this discussion • 790 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online